Zbigniew ZaslonaDr. Zbigniew Zaslona?currently?serves as?Director of Biology?at OncoArendi. He?obtained?his PhD in 2010 at the University of Giessen and the Marburg Lung Center in Germany, studying the mechanisms that modulate innate immunity in the context of pneumnia.?He then undertook a?postdoctoral fellowship at the University of Michigan in the USA, where he focused on pharmacological studies of GPCR receptors, in particular lipid mediators of inflammation.?From?2015?to October 2020, he?was?a research fellow at Trinity College Dublin (Ireland) in the Department of Biochemistry and Immunology, as well as?a Senior Investigator at the UK?biotechnology company?Sitryx?(which in March 2020 entered into a?$1?bln?collaboration and license?agreementacquired by Lillywith?Eli Lilly), where he was responsible for anti-inflammatory drug development programs. Dr. Zaslona is a recognized international expert in the field of inflammatory processes and lung?diseases and?is?repeatedly invited to lecture at?leading?international scientific conferences.? Read More Read Less